Skip to main content
logo
Coya Therapeutics, Inc. (COYA)
NASDAQ: COYA · Real-Time Price · USD
4.580
+0.030 (0.66%)
At close: Aug 6, 2026, 4:00 PM EDT
4.877
+0.297 (6.48%)
After-hours: Aug 6, 2026, 7:53 PM EDT

Coya Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
7.947.953.556--
Revenue Growth
115.44%123.57%-40.79%---
Gross Profit
7.947.953.556--
Operating Income
-22.52-22.56-17.25-7.9-9.81-4.87
Net Income
-21.13-21.23-14.88-7.99-12.24-4.89
Earnings Per Share
-1.15-1.27-0.98-0.79-4.73-1.89
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
50.7246.8238.3432.635.934.34
Total Debt
000012.970
Net Cash (Debt)
50.7246.8238.3432.63-7.034.34
Net Cash Growth
42.76%22.13%17.51%---
Net Cash Per Share
2.792.802.523.21-2.711.68

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-14.12-10.74-10.29-11.19-7.24-3.9
Capital Expenditures
------0.14
Free Cash Flow
-14.12-10.74-10.29-11.19-7.24-4.04
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%--
Operating Margin
-283.64%-283.87%-485.35%-131.67%--
Pretax Margin
-266.07%-267.10%-438.96%-121.02%--
Profit Margin
-266.11%-267.14%-418.70%-133.08%--
FCF Margin
-177.85%-135.16%-289.50%-186.41%--

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
13.5315.2826.9417.78--